Dividendos de SMS Pharmaceuticals
Dividendo controles de criterios 4/6
SMS Pharmaceuticals es una empresa que paga dividendos con una rentabilidad actual de 0.14% que está bien cubierta por los beneficios.
Información clave
0.1%
Rentabilidad por dividendo
9%
Ratio de pago
| Rentabilidad media de la industria | 0.7% |
| Próxima fecha de pago de dividendos | n/a |
| Fecha ex dividendo | n/a |
| Dividendo por acción | n/a |
| Beneficios por acción | ₹4.26 |
| Rentabilidad por dividendo prevista a 3 años | n/a |
Últimas actualizaciones de dividendos
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15Recent updates
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?
Oct 08Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?
Sep 17SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 26SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Could Signal Some Risk
Aug 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Business Is Trailing The Market But Its Shares Aren't
Aug 08SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Looks Just Right
Jul 25SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Matching Investor Opinion
Jul 07Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: Los dividendos por acción de SMSPHARMA se han mantenido estables en los últimos 10 años.
Dividendo creciente: El pago de dividendos de SMSPHARMA ha aumentado en los últimos 10 años.
Rentabilidad por dividendo vs. Mercado
| Rentabilidad por dividendo de SMS Pharmaceuticals vs. Mercado |
|---|
| Segmento | Rentabilidad por dividendo |
|---|---|
| Empresa (SMSPHARMA) | 0.1% |
| Suelo de mercado 25% (IN) | 0.3% |
| Techo de mercado 25% (IN) | 1.2% |
| Media de la industria (Pharmaceuticals) | 0.7% |
| Previsión de analistas en 3 años (SMSPHARMA) | n/a |
Dividendo destacado: El dividendo de SMSPHARMA(0.14%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Indian (0.27%).
Alto dividendo: El (0.14%) del dividendo de SMSPHARMA es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Indian (1.19%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: Con su bajo ratio de pago (8.8%), los pagos de dividendos de SMSPHARMA están totalmente cubiertos por los beneficios.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: Con su bajo ratio de pago en efectivo (7.4%), los pagos de dividendos de SMSPHARMA están totalmente cubiertos por los flujos de caja.